Prolongation of islet allograft survival.

Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment.

HLA-G dimers in the prolongation of kidney allograft survival.

Prolongation of rat cardiac allograft survival by donor pretreatment. Screening of antineoplastic drugs.

Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Prolongation of Cardiac Allograft Survival by Endometrial Regenerative Cells: Focusing on B-Cell Responses.

Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.

Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival.

Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.

Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.

Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow.

Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.

Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.

FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.

Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.

Prolongation of rat cardiac allograft survival by donor pretreatment. Impact of dose and timing of drug administration.

Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with "middle molecules".

Active enhancement in the primate by bone marrow. II. B cell antibody production and prolongation of liver allograft survival.

The combination of anti-NKG2D and CTLA-4 Ig therapy prolongs islet allograft survival in a murine model.

Prolongation of kidney survival during and after cyclosporin A therapy.

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Pre-transplant blood-transfusions and allograft survival.

Blood transfusion and renal allograft survival.

Long-term allograft survival after kidney transplantation.

Blood transfusions and renal allograft survival.

Suggest Documents

Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment.

HLA-G dimers in the prolongation of kidney allograft survival.

Prolongation of rat cardiac allograft survival by donor pretreatment. Screening of antineoplastic drugs.

Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Prolongation of Cardiac Allograft Survival by Endometrial Regenerative Cells: Focusing on B-Cell Responses.

Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.

Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival.

Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.

Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.

Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow.

Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.

Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.

FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.

Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.

Prolongation of rat cardiac allograft survival by donor pretreatment. Impact of dose and timing of drug administration.

Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with "middle molecules".

Active enhancement in the primate by bone marrow. II. B cell antibody production and prolongation of liver allograft survival.

The combination of anti-NKG2D and CTLA-4 Ig therapy prolongs islet allograft survival in a murine model.

Prolongation of kidney survival during and after cyclosporin A therapy.

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Pre-transplant blood-transfusions and allograft survival.

Blood transfusion and renal allograft survival.

Long-term allograft survival after kidney transplantation.

Blood transfusions and renal allograft survival.

Prolongation of islet allograft survival.

Recommend Documents

Follow Us